A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients
Core Binding Factor (CBF)-AML is one of the most common somatic mutations in acute myeloid leukemia (AML). t(8;21)/AML1-ETO-positive acute myeloid leukemia accounts for 5-10% of all AMLs. In this study, we consecutively included 254 AML1-ETO patients diagnosed and treated at our institute from Decem...
Main Authors: | Min Yang, Bide Zhao, Jinghan Wang, Yi Zhang, Chao Hu, Lixia Liu, Jiayue Qin, Feng Lou, Shanbo Cao, Chengcheng Wang, Wenjuan Yu, Hongyan Tong, Haitao Meng, Jian Huang, Honghu Zhu, Jie Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.783114/full |
Similar Items
-
A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation
by: Yi-Fan Zhang, et al.
Published: (2022-09-01) -
Etos Kerja dalam Perspektif Islam
by: Mohammad Irham
Published: (2012-04-01) -
Pandangan Al-Qur’an Dan Hadist Terhadap Etos Kerja
by: Fauziah Nurdin
Published: (2020-01-01) -
TURYSTYKA TATRZAŃSKA I ETOS TURYSTY W DOBIE NOWOCZESNOŚCI
by: Joanna Datko
Published: (2018-11-01) -
P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL
by: Huafeng Wang, et al.
Published: (2023-08-01)